{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T23:07:43Z","timestamp":1756076863622,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s40801-022-00295-6","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T14:02:40Z","timestamp":1646229760000},"page":"189-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2475-2621","authenticated-orcid":false,"given":"Qun-Ying","family":"Yue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5975-8858","authenticated-orcid":false,"given":"Pia","family":"Caduff-Janosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"295_CR1","unstructured":"Electronic Medicines Compendium: Summary of Product Characteristics for indapamide. https:\/\/www.medicines.org.uk\/EMC\/medicine\/26709\/SPC\/Indapamide+2.5mg+Tablets. Accessed 11 Nov 2020."},{"key":"295_CR2","unstructured":"Lozol (indapamide) lebel. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/018538s028lbl.pdf Accessed 11 Dec 2021."},{"key":"295_CR3","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/cc2978","volume":"9","author":"AL Huerta-Alard\u00edn","year":"2005","unstructured":"Huerta-Alard\u00edn AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis\u2014an overview for clinicians. Crit Care. 2005;9:158\u201369.","journal-title":"Crit Care"},{"key":"295_CR4","first-page":"129","volume":"11","author":"G Efstratiadis","year":"2007","unstructured":"Efstratiadis G, Voulgaridou A, Nikiforou D, Kyventidis A, Kourkouni E, Vergoulas G. Rhabdomyolysis updated. Hippokratia. 2007;11:129\u201337.","journal-title":"Hippokratia"},{"key":"295_CR5","first-page":"12","volume":"15","author":"PA Torres","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: pathogenesis. Diagn Treat. 2015;15:12.","journal-title":"Diagn Treat"},{"issue":"1","key":"295_CR6","first-page":"66","volume":"21","author":"VV Jain","year":"2011","unstructured":"Jain VV, Gupta OP, Jajoo SU, Khiangate B. Hypokalemia induced rhabdomyolysis. Indian. J Nephrol. 2011;21(1):66.","journal-title":"J Nephrol"},{"key":"295_CR7","unstructured":"World Health Organization Uppsala Monitoring Centre. https:\/\/www.who-umc.org\/vigibase\/vigibase. Accessed 25 Dec 2021."},{"issue":"8","key":"295_CR8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s40264-014-0204-5","volume":"37","author":"O Caster","year":"2014","unstructured":"Caster O, Juhlin K, Watson S, Nor\u00e9n GN. Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank. Drug Saf. 2014;37(8):617\u201328.","journal-title":"Drug Saf"},{"key":"295_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0962280211403604","volume":"22","author":"GN Nor\u00e9n","year":"2013","unstructured":"Nor\u00e9n GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. 2013;22:57\u201369.","journal-title":"Stat Methods Med Res"},{"key":"295_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2165\/00002018-200225060-00012","volume":"25","author":"SAW Shakir","year":"2002","unstructured":"Shakir SAW, Layton D. Causal association in pharmacovigilance and pharmacoepidemiology. Drug-Safety. 2002;25:467\u201371.","journal-title":"Drug-Safety."},{"issue":"4","key":"295_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00002018-200730040-00006","volume":"30","author":"M Perrio","year":"2007","unstructured":"Perrio M, Voss S, Shakir SA. Application of the Bradford Hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance. Drug Saf. 2007;30(4):333\u201346.","journal-title":"Drug Saf"},{"key":"295_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s40264-017-0509-2","volume":"40","author":"EI Ralph","year":"2017","unstructured":"Ralph EI. Causality assessment in pharmacovigilance: still a challenge. Drug Saf. 2017;40:365\u201372.","journal-title":"Drug Saf"},{"key":"295_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12982-015-0037-4","volume":"12","author":"KM Fedak","year":"2015","unstructured":"Fedak KM, Bernal A, Capshaw ZA, Gross S. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol. 2015;12:14.","journal-title":"Emerg Themes Epidemiol"},{"issue":"Suppl. 2","key":"295_CR14","first-page":"46","volume":"7","author":"A Fabbri","year":"2013","unstructured":"Fabbri A, Grifoni E, Marchiani C, et al. Indapamide-induced acute hypokaliemic rhabdomyolysis in a patient with primary hyperaldosteronism. Ital J Med. 2013;7(Suppl. 2):46\u20137.","journal-title":"Ital J Med"},{"key":"295_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/0976-500X.155488","volume":"6","author":"H Horwitz","year":"2015","unstructured":"Horwitz H, Woeien VA, Petersen LW, Jimenez-Solem E. Hypokalemia and rhabdomyolysis. J Pharmacol Pharmacother. 2015;6:98.","journal-title":"J Pharmacol Pharmacother"},{"issue":"4","key":"295_CR16","first-page":"146","volume":"63","author":"A van den Bosch","year":"2005","unstructured":"van den Bosch A, van der Klooster JM, Zuidgeest DM, Ouwendijk R, Dees A. Severe hypokalaemic paralysis and rhabdomyolysis due to ingestion of liquorice. Neth J Med [Internet]. 2005;63(4):146\u20138.","journal-title":"Neth J Med [Internet]."},{"issue":"2","key":"295_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00467-005-2045-z","volume":"21","author":"S Agrawal","year":"2006","unstructured":"Agrawal S, Agrawal V, Taneja A. Hypokalemia causing rhabdomyolysis resulting in life-threatening hyperkalemia. Pediatr Nephrol. 2006;21(2):289\u201391.","journal-title":"Pediatr Nephrol"},{"key":"295_CR18","doi-asserted-by":"publisher","first-page":"8053","DOI":"10.4076\/1757-1626-2-8053","volume":"2","author":"AC Meltem","year":"2009","unstructured":"Meltem AC, Figen C, Nalan MA, Mahir K, Sebnem B, Mehlika I, et al. A hypokalemic muscular weakness after licorice ingestion: a case report. Cases J. 2009;2:8053.","journal-title":"Cases J"},{"key":"295_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.4065\/78.6.767","volume":"78","author":"E Elinav","year":"2003","unstructured":"Elinav E, Chajek-Shaul T. Licorice consumption causing severe hypokalemic paralysis. Mayo Clin Proc. 2003;78:767\u20138.","journal-title":"Mayo Clin Proc"},{"key":"295_CR20","unstructured":"US FDA homepage. https:\/\/www.fda.gov\/consumers\/consumer-updates\/black-licorice-trick-or-treat. Accessed 20 Nov 2020."},{"key":"295_CR21","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000045413","volume":"82","author":"H Trimarchi","year":"1999","unstructured":"Trimarchi H, Gonzalez J, Olivero J. Hyponatremia-associated rhabdomyolysis. Nephron. 1999;82:274\u20137.","journal-title":"Nephron"},{"key":"295_CR22","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/ki.1985.229","volume":"28","author":"RL Tannen","year":"1985","unstructured":"Tannen RL. Diuretic-induced hypokalemia. Kidney Int. 1985;28:988\u20131000.","journal-title":"Kidney Int"},{"key":"295_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5049\/EBP.2010.8.1.51","volume":"8","author":"KS Hwang","year":"2010","unstructured":"Hwang KS, Kim G-H. Thiazide-induced hyponatremia. Electrolyte. Blood Press. 2010;8:51\u20137.","journal-title":"Blood Press"},{"key":"295_CR24","unstructured":"Antoniadis DJ, Vavouranakis EM, Tsioufis KP, Toutouzas PK. Rhabdomyolysis due to diuretic treatment, p3."},{"key":"295_CR25","first-page":"100","volume":"72","author":"SH Shin","year":"2016","unstructured":"Shin SH, Sun DS, Kim G, Kim YS, Yoon SA, Chang YS, et al. Two cases of hypokalemic rhabdomyolysis due to thiazide treatment. Korean J Med. 2016;72:100\u20134.","journal-title":"Korean J Med"},{"key":"295_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5935\/0103-507X.20150013","volume":"27","author":"DT Aguiar","year":"2015","unstructured":"Aguiar DT, Monteiro C, Coutinho P. Recurrent rhabdomyolysis secondary to hyponatremia in a patient with primary psychogenic polydipsia. Rev Bras Ter Intensiva. 2015;27:77\u201381.","journal-title":"Rev Bras Ter Intensiva."},{"key":"295_CR27","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1172\/JCI106976","volume":"51","author":"JP Knochel","year":"1972","unstructured":"Knochel JP, Schlein EM. On the mechanism of rhabdomyolysis in potassium depletion. J Clin Invest. 1972;51:1750.","journal-title":"J Clin Invest"},{"key":"295_CR28","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.4103\/2230-8210.119583","volume":"17","author":"MSA Cooray","year":"2013","unstructured":"Cooray MSA, Bulugahapitiya US, Peiris DN. Rhabdomyolysis: a rare presentation of aldosterone-producing adenoma. Indian J Endocrinol Metab. 2013;17:S237\u20139.","journal-title":"Indian J Endocrinol Metab."},{"key":"295_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0002-9343(82)90522-8","volume":"72","author":"JP Knochel","year":"1982","unstructured":"Knochel JP. Neuromuscular manifestations of electrolyte disorders. Am J Med. 1982;72:521\u201335.","journal-title":"Am J Med"},{"key":"295_CR30","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000441-200308000-00005","volume":"326","author":"RC Allison","year":"2003","unstructured":"Allison RC, Bedsole DL. The other medical causes of rhabdomyolysis. Am J Med Sci. 2003;326:79\u201388.","journal-title":"Am J Med Sci"},{"key":"295_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0272-6386(12)81095-X","volume":"21","author":"C Putterman","year":"1993","unstructured":"Putterman C, Levy L, Rubinger D. Transient exercise-induced water intoxication and rhabdomyolysis. Am J Kidney Dis. 1993;21:206\u20139.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"295_CR32","first-page":"177","volume":"64","author":"MI Freed","year":"1991","unstructured":"Freed MI, Rastegar A, Bia MJ. Effects of calcium channel blockers on potassium homeostasis. Yale J Biol Med. 1991;64(2):177\u201386.","journal-title":"Yale J Biol Med"},{"key":"295_CR33","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1751-7176.2008.08126.x","volume":"10","author":"SJ Mann","year":"2008","unstructured":"Mann SJ. The silent epidemic of thiazide-induced hyponatremia. J Clin Hypertens (Greenwich). 2008;10:477\u201384.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"5","key":"295_CR34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385\u201396.","journal-title":"Drug Saf"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-022-00295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-022-00295-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-022-00295-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T06:23:09Z","timestamp":1652768589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-022-00295-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["295"],"URL":"https:\/\/doi.org\/10.1007\/s40801-022-00295-6","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"type":"print","value":"2199-1154"},{"type":"electronic","value":"2198-9788"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"8 February 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to assist the preparation of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors are indebted to the national centres that make up the WHO Programme for International Drug Monitoring and contribute reports to VigiBase. However, the opinions and conclusions of this study are not necessarily those of the various centres, nor of WHO.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Qun-Ying Yue and Pia Caduff-Janosa have no conflicts of interest that are directly relevant to the content of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"This article is result of routine work of Uppsala Monitoring Centre. Ethical approval was not required for this study. The reports shared within the WHO Programme are deidentified, and research based on this data is not subject to ethics approval or informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated and analysed during the current study are not publicly available due to agreements between contributors of data to the database used (VigiBase) and the custodian of this database. National centres (mainly national drug regulatory authorities) constituting the WHO Programme for International Drug Monitoring (PIDM) contribute data to VigiBase and the Uppsala Monitoring Centre is the custodian in its capacity as WHO collaborating centre for international drug monitoring. Some subsets of the data may be available from the corresponding author on reasonable request<b>.<\/b>","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Dr. Yue designed and performed the study, and wrote the paper. Dr Caduff-Janosa conceived the study and revised the manuscript content. Both authors approved the final version of the manuscript.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contributions of authors statement"}}]}}